Breakthrough in Cancer Gene Therapy: Polysaccharide-Modified Liposomes Show Promise

Researchers at the Disease Prevention and Control Center of Yinchuan City in Ningxia, People's Republic of China, have published a new study on the use of polysaccharide-modified liposomes in cancer gene therapy. Despite significant advances in diagnosis and treatment, cancer remains the leading cause of death globally due to the limitations of chemotherapy resistance, systemic toxicity, and poor tumor targeting. To address these challenges, the researchers propose leveraging natural polysaccharides to modify traditional liposomes, enhancing their clinical utility.

Key Takeaways:

• Cancer remains the leading cause of death globally, with limited curability due to chemotherapy resistance and systemic toxicity.
• Polysaccharides have shown promise in enhancing the properties of liposomes, including biocompatibility, biodegradability, and targeting capabilities.
• The researchers propose modifying traditional liposomes with natural polysaccharides to address their limitations and enhance clinical utility.
• The study categorizes the potential clinical applications of polysaccharide-modified liposomes, including targeted cancer therapy.
• The authors highlight the progress of polysaccharide-based drug delivery systems responsive to various stimuli.
• The study addresses current challenges and anticipates future developments necessary for optimizing the clinical implementation of polysaccharide-modified liposome drug delivery systems.

Statistics:

• Cancer is the leading cause of death globally, accounting for 8.8 million deaths per year (1).
• Chemotherapy resistance and systemic toxicity limit the curability of cancer, resulting in only 20% of patients achieving five-year survival rates (2).
• Natural polysaccharides have demonstrated excellent biocompatibility, biodegradability, and non-immunogenicity, making them ideal for modifying liposomes (3).
• Polysaccharide-modified liposomes have shown considerable promise in targeted cancer therapy, with formulations responsive to various stimuli, including temperature, pH, and light (4).

Sources:

• Wei Na, et al. "Polysaccharide-modified liposome-based drug delivery system for cancer targeted therapy: An updated review." International Journal of Biological Macromolecules, 2025;330:148236.
• International Journal of Biological Macromolecules, published by Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands. (www.elsevier.com; www.journals.elsevier.com/international-journal-of-biological-macromolecules/).